These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20958104)
1. Pharmacological treatment of obesity in children and adolescents: current status and perspectives. Catoira N; Nagel M; Di Girolamo G; Gonzalez CD Expert Opin Pharmacother; 2010 Dec; 11(18):2973-83. PubMed ID: 20958104 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic agents for the treatment of obesity. Mathys M Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086 [TBL] [Abstract][Full Text] [Related]
11. The new role of pharmacotherapy for weight reduction in obesity. Fernstrom MH; Fernstrom JD Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983 [TBL] [Abstract][Full Text] [Related]
12. [Long way towards a successful drug treatment of obesity]. Rössner S Lakartidningen; 2011 Dec 7-13; 108(49):2578-80. PubMed ID: 22468394 [No Abstract] [Full Text] [Related]
13. [The principle of precaution and the drug treatment of obese subjects]. C-Soriguer FJ; Tinahones FJ Med Clin (Barc); 1999 Apr; 112(13):503-7. PubMed ID: 10353118 [No Abstract] [Full Text] [Related]
14. An update on the pharmacological treatment of obesity. Schnee DM; Zaiken K; McCloskey WW Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of obesity. Linné Y; Rössner S Clin Dermatol; 2004; 22(4):319-24. PubMed ID: 15475233 [TBL] [Abstract][Full Text] [Related]
16. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Fujioka K Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacotherapy of obesity]. Svendsen OL Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112 [No Abstract] [Full Text] [Related]
19. Anti-obesity drugs: use, mechanisms and clinical importance. Adam O; Forth W Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630 [TBL] [Abstract][Full Text] [Related]
20. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat. Scheen AJ; Ernest P Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]